Lamisil

Terbinafine, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for skin application. It is used to treat fungal infections of the skin, hair and nails in both adult and pediatric patients when prescribed by a healthcare professional.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Customers benefit from reliable supply chains and responsive technical support.

Terbinafine is an allylamine antifungal used to treat superficial fungal infections of the skin and nails. - Tinea pedis: alleviates itching and clears fungal infection of the feet. - Tinea corporis: reduces lesions and eliminates the causative dermatophytes on the body. - Tinea cruris: improves redness and scaling in the groin area. - Tinea unguium (onychomycosis): promotes clearance of fungal infection in the nails.

Topical terbinafine may cause local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Burning sensation: transient warmth at the application site. - Itching: mild pruritus around treated area. - Redness: localized erythema. - Dryness or peeling: mild skin desquamation.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Contact dermatitis: intense rash with blistering. - Systemic toxicity: rare liver enzyme elevation if absorbed in large amounts.

When using Lamisil topical, observe the following precautions to minimize adverse reactions and ensure effectiveness. - Apply only to intact skin: avoid open wounds or broken skin. - Limit use to prescribed areas: do not spread to unaffected regions. - Avoid concurrent use of other topical antifungals unless directed. - Discontinue if signs of allergic reaction appear: seek medical advice. - Keep out of reach of children: store safely. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Terbinafine topical can interact with certain substances; awareness of these interactions helps prevent reduced efficacy or increased irritation.

Major Interactions (Avoid): - Concurrent systemic terbinafine therapy: may increase systemic exposure and risk of toxicity. - Use with strong keratolytic agents (e.g., salicylic acid) on the same site: can enhance skin irritation.

Moderate Interactions (Monitor Closely): - Co‑application with other topical antifungals: may increase local irritation. - Use with corticosteroid creams: may mask signs of infection. - CYP2D6 inhibitors (if systemic absorption occurs): could affect metabolism of systemic terbinafine. - Alcohol consumption: may exacerbate skin dryness.